Serviços Personalizados
Journal
Artigo
Indicadores
- Citado por SciELO
- Acessos
Links relacionados
- Similares em SciELO
Compartilhar
Archivos de cardiología de México
versão On-line ISSN 1665-1731versão impressa ISSN 1405-9940
Resumo
RODRIGUEZ CHAVEZ, Laura Leticia. Drugs for heart rate control and non-antiarrhythmic drugs in atrial fibrillation. Arch. Cardiol. Méx. [online]. 2007, vol.77, suppl.2, pp.54-58. ISSN 1665-1731.
Multiple drugs are helpful for rate control in different tachyarrhythmias, in particular atrial fibrillation (AF). Betablockers (βB) and calcium channel blockers have been used as monotherapy or as adjunctive therapy to antiarrhythmics for mantaining an acceptable ventricular rate. In recent years new concepts about auricular remodelation process as a consequence of AF has shown benefits with drugs as angiotensin-renin system blockers (ARSB) like angiotensin conversing enzime inhibitors (ACEI) and angiotensin receptor blockers (ARB). In this article it will be reviewed the benefits of rate control in AF by using βB and calcium channel blockers and also the benefits in atrial remodelation process and the prevention of AF with ARSB drugs.
Palavras-chave : Atrial fibrillation; Betablockers; Calcium channel blockers; Angiotensin receptor blockers.